Wilson DP, et al. Clin Lipidol. 2019;13(3):374-92. Reyes-Soffer G, et al. Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60. Kronenberg F, et al.Eur Heart J. 2022;43(39):3925-3946. Tsimikas S, Stroes ESG. Atherosclerosis. 2020;300:1-9. Tsimikas S, et al. J Am Coll...
Amgen announced data from the final analysis of the Phase 2 OCEAN-DOSE study of olpasiran, a small interfering RNA during the Late-Breaking Science Session at the European Society of Cardiology Annual Meeting being held in Amsterdam.
Sustainalytics *** ESG Risk Rating *** Bond classification Senior Unsecured Coupon bonds Trace-eligible Show more Restructuring *** Holders Holder Market value, mln Disclosure date Vanguard Total Bond Market ETF (USD) *** 28/02/2025 Vanguard Short-Term Corporate Bond ETF (USD) *** ...